Satellite Symposia

Find below a list of all Satellite Symposia of EANM’21. Further details such as Symposium Title and Content will follow soon.

 

Wednesday, October 20, 10:15 – 11:00 | Satellite Symposia by

GE HEALTHCARE

What is the Future of SPECT Imaging?

Channel 3
Session Details

Programme Details:

Transition to Whole Body SPECT/CT
Prof. Vineet Prakash
Royal Surrey County Hospital, Guildford, UK

Alexander Smout
Royal Surrey Country Hospital, Guildford, UK

3D CZT SPECT/CT: First Clinical Experience with StarGuide
Dr. Matthieu Bailly
Head of the Nuclear Medicine Department, NM Physician, Hospital of Orléans, France

Wednesday, October 20, 11:00 – 11:45 | Satellite Symposia by

SIRTEX

SIRT with SIR-Spheres® Y-90 resin microspheres – Best practice and realworld evidence

Channel 3

Session Details

Programme Details:

Agenda:

11.00: Follow the recommendation – Dr. Arnaud Dieudonné

11.15: CIRT – Real world evidence that matters for patients – Prof. Niklaus Schäfer

11.30: Q&A

Wednesday, October 20, 12:00 – 13:30 | Satellite Symposia by

ADVANCED ACCELERATOR APPLICATIONS, A NOVARTIS COMPANY

Targeting PSMA in advanced prostate cancer: How will precision medicine evolve patient care?

Channel 3

Session Details

Agenda:

12:00 – 12:05 – Welcome and Introduction – Joe O’Sullivan (Chair), UK

12:05 – 12:35 – Revealing Gaps in the Advanced Prostate Cancer Treatment Landscape – Noel Clarke, UK; Elena Castro, Spain

12:35 – 12:50 – Precision Medicine: A New Era of Imaging-based Patient Selection – Wim Oyen, The Netherlands

12:50 – 13:00 – Radiopharmaceuticals in Advanced Prostate Cancer: Past and Future – Joe O’Sullivan, UK

13:00 – 13:30 – Panel discussion: Maximising MDT collaboration in clinical practice – Led by Joe O’Sullivan, all

 

Wednesday, October 20, 13:50 – 14:15 | Satellite Symposia by

HERMES MEDICAL SOLUTIONS

Innovations for personalized, fast and accurate dosimetry

Channel 3
Session Details

Agenda

Welcoming words
Tom Francke, CEO, Assoc. Prof.,
Hermes Medical Solutions, Stockholm, Sweden

Impact of Dosimetry in Translational Research –
Added Value for Probe Developments?

Frederik L. Giesel, MD, Chairman of the Nuclear Medicine
Department at the University Hospital Düsseldorf, Germany

Latest Innovation in Dosimetry Software
Helena McMeekin, MSc. Clinical Applications Scientist,
Hermes Medical Solutions, UK

Lu-177 PRRT Dosimetry in Clinical Practice
Lydia Ram, Trainee Clinical Scientist,
Queen Elizabeth Hospital, Birmingham, UK

Followed by a live Q&A with the speakers – 14:20– 14:40 CEST

 

Wednesday, October 20, 16:15 – 17:45 | Satellite Symposia by

ADVANCED ACCELERATOR APPLICATIONS, A NOVARTIS COMPANY

Advancing towards precision medicine with theranostics in oncology

Channel 3
Session Details

Agenda

Speaker: Shaunak Navalkissoor
16:15–16:25: Welcome and introduction

Speaker: Vikas Prasad
16:25–16:45: Moving towards precision medicine with RLT: Advances in imaging

Speaker: Andrea Frilling
16:45–17:05: Moving towards precision medicine with RLT: Advances in blood biomarkers

Speaker: Shaunak Navalkissoor
17:05–17:20: Moving towards precision medicine with RLT: Evolving theranostics in and beyond NETs

Panel discussion
17:20–17:40: How can we make the best use of all tools available for optimal patient outcomes?

Speaker: Shaunak Navalkissoor
17:40–17:45: Summary and conclusion

Wednesday, October 20, 18:00 – 19:30 | Satellite Symposia by

TELIX PHARMACEUTICALS

The evolution of prostate cancer knowledge through PSMA

Channel 3
Session Details

Title: The evolution of prostate cancer knowledge through PSMA

Moderator: Dr. Laura Ravasi, Telix Pharmaceuticals
18.00: Session introduction

Speaker 1: Professor Louise Emmett, Director of Theranostics and Nuclear medicine at St Vincent’s Hospital Sydney, Australia
18.05-18.40: Evolution of diagnostic imaging in prostate cancer: then and now

Speaker 2: Associate Professor Jochen Christoph Walz, Head of the Department of Urology at the Institut Paoli-Calmettes Cancer Centre in Marseille, France
18.40-19.15: The evolution in patient’s management through PSMA

Speaker 3: Professor Dr. Ken Herrmann, Director of Clinic of Nuclear Medicine at University Hospital of Essen, Germany
19.15-1930: The evolution in therapeutic options as PSMA is an actionable target

Closing remarks from Laura Ravasi  

Thursday, October 21, 09:00 – 09:45 | Satellite Symposia by

GE HEALTHCARE

Digital Technology: Impacts on Cardiac Imaging

Channel 3
Session Details

Programme Details:

Easy Patient Management with New Cardiac CZT
Prof. Tali Sharir, MD
Director of Nuclear Cardiology, Assuta Medical Center, Tel Aviv, Israel

Modern Diagnosis in Cardiac Diseases with PET/CT
Prof. Juhani Knuuti, MD, FESC
University of Turku and Turku University Hospital, Turku, Finland

Implementing Production of 13N-ammonia in an In-House PET Radiopharmacy
Dr. Tom Christian Holm Adamsen, Ph. D.
Chief Radiochemist / Head of Production Centre for Nuclear Medicine Haukeland University Hospital Bergen, Norway

 

Thursday, October 21, 09:45 – 10:30 | Satellite Symposia by

GE HEALTHCARE

Overcoming the DLB Diagnosis Challenge: Perspectives for Neurologists and Nuclear Medicine Physicians

Channel 3
Session Details

Programme Details:

Prof. John O‘Brien
Professor of Old Age Psychiatry, University of Cambridge

Dr. George Petrides
Consultant Radionuclide Radiologist, Newcastle Upon Tyne Hospitals

Zulfiqar Haider (host)
Global Medical Lead Neurology, GE Healthcare

Thursday, October 21, 10:45 – 12:15 | Industry Symposia by

GE HEALTHCARE

How do Innovations Support Theranostics?

Channel 3
Session Details

Programme Details:

Ben Newton (host)
General Manager Oncology, GE Healthcare

The Future of Precision Diagnostics – Immune PET
Prof. Rod Hicks
University of Melbourne, Australia

Dr. Simon Williams D.Phil
Department of Biomedical Imaging, Genentech Inc., USA

The place of SPECT in Theranostics
Prof. Michael C. Kreissl
Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Germany

Prostate Cancer – the Role of PSMA PET
Prof. Dr. Karolien Goffin, MD PhD
Nuclear Medicine & Molecular Imaging & PET-MR unit, University Hospital Leuven – KU Leuven, Belgium

How to Get your Clinic Ready for a Theragnostics Approach?
Prof. Andrei Iagaru, MD
Professor of Radiology – Nuclear Medicine and Chief of the Division of Nuclear Medicine and Molecular Imaging at Stanford University, USA

 

Thursday, October 21, 10:45 – 12:15 | Satellite Symposia by

SIEMENS HEALTHINEERS

Establishing molecular imaging for tomorrow, with technology of today

Channel 2
Session Details

Chairperson: Collin Schaeffer, Global product marketing operations manager, Siemens Healthineers Molecular Imaging, Hoffman Estates, Illinois, USA

Programme Details:

10:50-11:20: Radiomics and Genomics – a match made in heaven?
Prof. Dr. Alexander Haug, MD, PhD
Division of Nuclear Medicine, Medical University of Vienna, Vienna, Austria

11:20-11:50: Quantification of myocardial 99mTc-HMDP uptake in patients with transthyretin-related cardiac amyloidosis: ready for clinical practice?
Prof. Alban Bailliez, MD, PhD and
Nuclear Medicine Department-Humani TEP, Faculty of Medicine, Lille, France

Dr. Dimitri Bellevre, MD, PhD student
Nuclear Medicine Department-Humani TEP, Faculty of Medicine, Lille, France

11:50-12:10: Integrated intelligence in molecular imaging: today and tomorrow
Bruce Spottiswoode, PhD
Director, Clinical Applications Research, Siemens Healthineers Molecular Imaging, Knoxville, TN, USA

Carl von Gall, MD
Product Manager Clinical Applications Oncology, Siemens Healthineers Molecular Imaging, Knoxville, TN, USA

Thursday, October 21, 15:05 – 16:35 | Satellite Symposia by

TERUMO INTERVENTIONAL SYSTEMS

Channel 3
Session Details

EANM 2021 – Virtual event – October 20-23
Date & time: Thursday Oct. 21, 15:05 – 16:35
Symposium title: Establishing Individualised SIRT dosimetry with The Holmium Platform
Chair: Prof. Dr. M. Lam

Agenda

  • Upcoming EANM SIRT guidelines – Dr. M.M. Weber (University Hospital Essen, Germany)
  • Starting with Holmium-166 SIRT in clinical practice – Dr. A. Oliveira (São João Hospital, Portugal)
  • Individualized SIRT treatment planning & verification with the Holmium Platform: Practical aspects – PD Dr. R. Drescher (University Hospital Jena, Germany)
  • Latest Holmium data & The Clinical Roadmap – Prof. Dr. M. Lam (UMC Utrecht, Netherlands)
  • Future Innovations of Holmium-166 SIRT: Real time MR guided SIRT – Prof. Dr. J. Fütterer (Radboud UMC, The Netherlands)

Thursday, October 21, 16:50 – 18:20 | Satellite Symposia by

PEERVOICE
Current and Emerging Radiopharmaceuticals for Prostate Cancer: Is There a Role for Both?

Channel 3
Session Details

Agenda

Neal Shore, MD, FACs (Myrtle Beach, South Carolina, USA)
16:50–16:55: Welcome and Introduction

Ken Herrmann, MD, MBA (Essen, Germany)
16:55–17:05: Evolving Radiotherapeutic Landscape in Metastatic Prostate Cancer

Joe O’Sullivan, MD, FRCPI, FFRRCSI, FRCR (Belfast, Northern Ireland)
17:05–17:15: The Patient Journey and the Place of Radiotherapies: Understanding How Patient Profiles Align With Clinical Evidence

Neal Shore, MD, FACs (Myrtle Beach, South Carolina, USA)
17:15–17:25: Sequencing Radiotherapeutics in mPC: What Does the Data Tell Us?

Panel
17:25–17:55: Cases in Practice: Identifying the Right Time for Radiopharmaceuticals in Men with mPC

Neal Shore, MD, FACs (Myrtle Beach, South Carolina, USA) and Ken Herrmann, MD, MBA (Essen, Germany)
17:55–18:20: “Ask the Faculty” and Take-Home Messages

 

Friday, October 22, 09:00 – 09:45 | Satellite Symposia by

GE HEALTHCARE

Integrating PET Innovations into Practice

Channel 3
Session Details

Programme Details:

Clinical Translation of Digital PET/CT innovations
Dr. Martin W Hüellner, PD, Dr. med.
Department of Nuclear Medicine University Hospital Zurich / University of Zurich, Switzerland

An Evaluation of the Effects of PET timing Resolution Versus NEC on Image Quality
Dr. Paul E. Kinahan PhD
Professor and Vice-Chair for Radiology Research, University of Washington, Seattle, USA

 

Friday, October 22, 09:45 – 10:30 | Satellite Symposia by

GE HEALTHCARE

Utility of Amyloid PET in the Diagnosis of Dementia

Channel 3
Session Details

Programme Details:

Prof. Renaud Lhommel, MD
Cliniques Universitaires Saint-Luc UCL, Brussels, Belgium

Prof. Bernard Hanseeuw MD PhD
Cliniques Universitaires Saint-Luc UCL, Brussels, Belgium

Gill Farrar PhD (host)
Global Medical Director, Neurology GE Healthcare

 

Friday, October 22, 10:45 – 11:30 | Satellite Symposia by

SIRTEX

SIRT with SIR-Spheres® Y-90 resin microspheres – Case by Case

Channel 3

Session Details

Programme Details:

Agenda:

10.45: Patient Case 1 – Downsizing (mCRC) – Dr. Macarena Rodríguez-Fraile

11.00: CIRT – Patient Case 2 – Bilobar Treatment (HCC) – Dr. Julia Brosch-Lenz

11.15: Patient Case 3 – Super-selective Treatment (HCC) – Dr. Mathias Zacherl

Friday, October 22, 15:05 – 16:35 | Satellite Symposia by

BOSTON SCIENTIFIC

From HCC to Liver mCRC, accelerating treatment standards with Y-90 glass microspheres

Channel 3
Session Details

Chairperson: Prof. Marnix Lam, Nuclear Medicine, University Medical Centre Utrecht, Netherlands

Talk 1: What have we learnt from treating HCC?
Prof. Niklaus Schaefer, Medical Oncology & Nuclear Medicine, Lausanne University Hospital, Switzerland

Talk 2: EPOCH study design & results
Dr Manuel Weber, Nuclear Medicine, Essen University Hospital, Germany

Talk 3: Dose response & dose toxicity relationship for Y-90 glass SIRT in CLM Prof. Marnix Lam, Nuclear Medicine, University Medical Centre Utrecht, Netherlands

 

Friday, October 22, 16:50 – 18:20 | Satellite Symposia by

SPECTRUM DYNAMICS

Innovations That Transform SPECT Imaging

CZT-based detector technology with unique scanner designs:
clinical transformation of workflow; image quality and quantitation

Channel 3
Session Details

Programme Details:

Cardiology Imaging

  • The significance of Emission Based Attenuation Correction in Myocardial Perfusion Imaging: an AI Application for routine implementation: TruCorr
  • CZT SPECT Myocardial Blood flow role and relevance: clinical experience

SPECT/CT Imaging

  • Localization and characterization: Role of the VERITON-CT SPECT/CT camera in the diagnosis of parathyroid adenomas
  • Beyond Total-Body NM/CT Imaging: In vivo imaging with dynamic 3600CZT SPECT/CT; SUV quantitation impact in SPECT.

Speakers:

James Case, PhD, MASNC
Cardiovascular Imaging Technologies
Kansas City, MO

Miguel Ochoa Figueroa, MD, PhD. ​
Nuclear Medicine in Dpt. of Clinical Physiology
Dpt. Of Radiology.​
Linköping University Hospital.​
Sweden.​

Pr. Wanda Acampa, MD
Department of Advanced Biomedical Science
University Federico II of Naples

Pr. Pierre-Yves Marie; MD, PhD
Head, Department of Nuclear Medicine
Dr. Laetitia Imbert, PhD
Medical Physicist
Department of Nuclear Medicine
University Hospital of Nancy, France